Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
Saved in:
| Title: | Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. |
|---|---|
| Authors: | Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Subramaniam A; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zheng J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amini B; Musculoskeletal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Trinh VA; Department of Clinical Pharmacy Services, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Joseph J; Department of Clinical Pharmacy Services, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mennel RG; Texas Oncology-Baylor Charles A. Sammons Center, Dallas, Texas, USA., Bishop AJ; Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yalamanchili S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Botello G; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stephen B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel AB; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3383-3391. Date of Electronic Publication: 2022 Jul 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35792683 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ravi+V%22">Ravi V</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Subramaniam+A%22">Subramaniam A</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+J%22">Zheng J</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Amini+B%22">Amini B</searchLink>; Musculoskeletal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Trinh+VA%22">Trinh VA</searchLink>; Department of Clinical Pharmacy Services, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Joseph+J%22">Joseph J</searchLink>; Department of Clinical Pharmacy Services, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Mennel+RG%22">Mennel RG</searchLink>; Texas Oncology-Baylor Charles A. Sammons Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bishop+AJ%22">Bishop AJ</searchLink>; Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Sturgis+EM%22">Sturgis EM</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Goepfert+RP%22">Goepfert RP</searchLink>; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Yalamanchili+S%22">Yalamanchili S</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Botello+G%22">Botello G</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Stephen+B%22">Stephen B</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Piha-Paul+SA%22">Piha-Paul SA</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Patel+AB%22">Patel AB</searchLink>; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Benjamin+RS%22">Benjamin RS</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Patel+SR%22">Patel SR</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Futreal+PA%22">Futreal PA</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Somaiah+N%22">Somaiah N</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Naing+A%22">Naing A</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3383-3391. <i>Date of Electronic Publication: </i>2022 Jul 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35792683 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.34370 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3383 Titles: – TitleFull: Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ravi V – PersonEntity: Name: NameFull: Subramaniam A – PersonEntity: Name: NameFull: Zheng J – PersonEntity: Name: NameFull: Amini B – PersonEntity: Name: NameFull: Trinh VA – PersonEntity: Name: NameFull: Joseph J – PersonEntity: Name: NameFull: Mennel RG – PersonEntity: Name: NameFull: Bishop AJ – PersonEntity: Name: NameFull: Sturgis EM – PersonEntity: Name: NameFull: Goepfert RP – PersonEntity: Name: NameFull: Yalamanchili S – PersonEntity: Name: NameFull: Botello G – PersonEntity: Name: NameFull: Stephen B – PersonEntity: Name: NameFull: Piha-Paul SA – PersonEntity: Name: NameFull: Patel AB – PersonEntity: Name: NameFull: Lazar AJ – PersonEntity: Name: NameFull: Conley AP – PersonEntity: Name: NameFull: Benjamin RS – PersonEntity: Name: NameFull: Patel SR – PersonEntity: Name: NameFull: Futreal PA – PersonEntity: Name: NameFull: Somaiah N – PersonEntity: Name: NameFull: Naing A IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2022 Sep 15 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 128 – Type: issue Value: 18 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |